Research protocols generally specify the route of administration. The two most common methods for peptides are Subcutaneous (SubQ) and Intramuscular (IM). Understanding the difference is key to replicating study results. Learn how to organize a multi-peptide protocol to track these variables.
Subcutaneous (SubQ)
Definition: Injection into the adipose (fat) tissue layer, just beneath the skin but above the muscle.
Why it's preferred for peptides:
- Sustained Release: Fat has poor blood flow compared to muscle. This allows the peptide to be absorbed slowly and steadily over hours, mimicking the body's natural pulsatile secretion (especially for GHRH/GHRPs).
- Ease: It is less painful and easier to perform on oneself.
- Sites: Common research sites include the abdominal area (2 inches away from the navel) or the outer thigh.
Intramuscular (IM)
Definition: Injection deep into the muscle belly.
Use Cases:
- Fast Absorption: Muscle is highly vascular. Compounds hit the bloodstream much faster. This might be desirable for certain performance protocols but can lead to a "spike and crash" for others.
- Volume: Muscle can hold more liquid than fat tissue. If a protocol requires injecting >1ml at once, IM is often necessary to avoid lumps/irritation.
Needle Selection
- SubQ: Short needles (5/16" or 1/2" length). High gauge (29G-31G) for comfort. Check reading an insulin syringe.
- IM: Longer needles (1" or 1.5") to penetrate fat and reach muscle. Lower gauge (25G-27G).
Track your site rotation and routes using visualizing dosing charts and learn how to track protocols without an account. Always follow peptide storage guidelines to ensure the product you are administering is effective.